https://stock.noler.com/us/stock/myovant-sciences-ltd https://stock.noler.com/us/stock/myovant-sciences-ltd/accounts-payable https://stock.noler.com/us/stock/myovant-sciences-ltd/accounts-payable-and-accrued-liabilities-current https://stock.noler.com/us/stock/myovant-sciences-ltd/accounts-receivable https://stock.noler.com/us/stock/myovant-sciences-ltd/accrued-income-taxes-current https://stock.noler.com/us/stock/myovant-sciences-ltd/accrued-liabilities-current https://stock.noler.com/us/stock/myovant-sciences-ltd/accrued-professional-fees-current https://stock.noler.com/us/stock/myovant-sciences-ltd/accrued-royalties-current https://stock.noler.com/us/stock/myovant-sciences-ltd/accumulated-oci-foreign-currency-translation-adjustment-net-of-tax https://stock.noler.com/us/stock/myovant-sciences-ltd/additional-paid-in-capital https://stock.noler.com/us/stock/myovant-sciences-ltd/advertising-expense https://stock.noler.com/us/stock/myovant-sciences-ltd/allocated-share-based-compensation-expense https://stock.noler.com/us/stock/myovant-sciences-ltd/amortization-of-financing-costs-and-discounts https://stock.noler.com/us/stock/myovant-sciences-ltd/antidilutive-securities-excluded-from-computation-of-earnings-per-share-amount https://stock.noler.com/us/stock/myovant-sciences-ltd/assets-fair-value-disclosure https://stock.noler.com/us/stock/myovant-sciences-ltd/available-for-sale-debt-realized-gain-loss https://stock.noler.com/us/stock/myovant-sciences-ltd/basic-shares https://stock.noler.com/us/stock/myovant-sciences-ltd/capital-expenditures https://stock.noler.com/us/stock/myovant-sciences-ltd/capital-expenditures-incurred-but-not-yet-paid https://stock.noler.com/us/stock/myovant-sciences-ltd/cash https://stock.noler.com/us/stock/myovant-sciences-ltd/cash-and-cash-equivalents-change https://stock.noler.com/us/stock/myovant-sciences-ltd/cash-and-equivalents https://stock.noler.com/us/stock/myovant-sciences-ltd/cash-and-restricted-cash https://stock.noler.com/us/stock/myovant-sciences-ltd/cash-cash-equivalents-and-short-term-investments https://stock.noler.com/us/stock/myovant-sciences-ltd/cash-flow-breakdown https://stock.noler.com/us/stock/myovant-sciences-ltd/class-of-warrant-or-right-exercise-price-of-warrants-or-rights https://stock.noler.com/us/stock/myovant-sciences-ltd/class-of-warrant-or-right-number-of-securities-called-by-warrants-or-rights https://stock.noler.com/us/stock/myovant-sciences-ltd/common-stock-capital-shares-reserved-for-future-issuance https://stock.noler.com/us/stock/myovant-sciences-ltd/common-stock-par-or-stated-value-per-share https://stock.noler.com/us/stock/myovant-sciences-ltd/common-stock-share-subscribed-but-unissued-subscriptions-receivable https://stock.noler.com/us/stock/myovant-sciences-ltd/common-stock-value https://stock.noler.com/us/stock/myovant-sciences-ltd/comprehensive-income https://stock.noler.com/us/stock/myovant-sciences-ltd/contract-liability https://stock.noler.com/us/stock/myovant-sciences-ltd/contract-with-customer-asset-net https://stock.noler.com/us/stock/myovant-sciences-ltd/contract-with-customer-receivable-after-allowance-for-credit-loss https://stock.noler.com/us/stock/myovant-sciences-ltd/contractual-obligation https://stock.noler.com/us/stock/myovant-sciences-ltd/contractual-obligation-due-after-fifth-year https://stock.noler.com/us/stock/myovant-sciences-ltd/contractual-obligation-due-in-fifth-year https://stock.noler.com/us/stock/myovant-sciences-ltd/contractual-obligation-due-in-fourth-year https://stock.noler.com/us/stock/myovant-sciences-ltd/contractual-obligation-due-in-next-twelve-months https://stock.noler.com/us/stock/myovant-sciences-ltd/contractual-obligation-due-in-second-year https://stock.noler.com/us/stock/myovant-sciences-ltd/contractual-obligation-due-in-third-year https://stock.noler.com/us/stock/myovant-sciences-ltd/cover-page-shares-outstanding https://stock.noler.com/us/stock/myovant-sciences-ltd/cumulative-effect-of-new-accounting-principle-in-period-of-adoption https://stock.noler.com/us/stock/myovant-sciences-ltd/current-assets https://stock.noler.com/us/stock/myovant-sciences-ltd/current-federal-tax-expense-benefit https://stock.noler.com/us/stock/myovant-sciences-ltd/current-income-tax-expense-benefit https://stock.noler.com/us/stock/myovant-sciences-ltd/current-liabilities https://stock.noler.com/us/stock/myovant-sciences-ltd/current-portion-of-long-term-debt https://stock.noler.com/us/stock/myovant-sciences-ltd/debt-carrying-amount https://stock.noler.com/us/stock/myovant-sciences-ltd/debt-issuance-costs-incurred-during-noncash-or-partial-noncash-transaction https://stock.noler.com/us/stock/myovant-sciences-ltd/debt-maturing-after-year-five https://stock.noler.com/us/stock/myovant-sciences-ltd/debt-maturing-in-next-twelve-months https://stock.noler.com/us/stock/myovant-sciences-ltd/debt-maturing-in-year-five https://stock.noler.com/us/stock/myovant-sciences-ltd/debt-maturing-in-year-four https://stock.noler.com/us/stock/myovant-sciences-ltd/debt-maturing-in-year-three https://stock.noler.com/us/stock/myovant-sciences-ltd/debt-maturing-in-year-two https://stock.noler.com/us/stock/myovant-sciences-ltd/debt-unamortized-discount-premium-and-debt-issuance-costs-net https://stock.noler.com/us/stock/myovant-sciences-ltd/deferred-compensation-share-based-arrangements-liability-current https://stock.noler.com/us/stock/myovant-sciences-ltd/deferred-federal-income-tax-expense-benefit https://stock.noler.com/us/stock/myovant-sciences-ltd/deferred-income-tax-assets-net https://stock.noler.com/us/stock/myovant-sciences-ltd/deferred-income-tax-expense-benefit https://stock.noler.com/us/stock/myovant-sciences-ltd/deferred-offering-costs https://stock.noler.com/us/stock/myovant-sciences-ltd/deferred-rent-credit-noncurrent https://stock.noler.com/us/stock/myovant-sciences-ltd/deferred-revenue https://stock.noler.com/us/stock/myovant-sciences-ltd/deferred-revenue-2 https://stock.noler.com/us/stock/myovant-sciences-ltd/deferred-revenue-noncurrent https://stock.noler.com/us/stock/myovant-sciences-ltd/deferred-revenue-recognized https://stock.noler.com/us/stock/myovant-sciences-ltd/deferred-tax-assets-goodwill-and-intangible-assets https://stock.noler.com/us/stock/myovant-sciences-ltd/deferred-tax-assets-gross https://stock.noler.com/us/stock/myovant-sciences-ltd/deferred-tax-assets-liabilities-net https://stock.noler.com/us/stock/myovant-sciences-ltd/deferred-tax-assets-net https://stock.noler.com/us/stock/myovant-sciences-ltd/deferred-tax-assets-operating-loss-carryforwards-foreign https://stock.noler.com/us/stock/myovant-sciences-ltd/deferred-tax-assets-other https://stock.noler.com/us/stock/myovant-sciences-ltd/deferred-tax-assets-stock-compensation https://stock.noler.com/us/stock/myovant-sciences-ltd/deferred-tax-assets-tax-credit-carryforwards-research https://stock.noler.com/us/stock/myovant-sciences-ltd/deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/myovant-sciences-ltd/deferred-tax-liabilities-leasing-arrangements https://stock.noler.com/us/stock/myovant-sciences-ltd/deferred-tax-liabilities-property-plant-and-equipment https://stock.noler.com/us/stock/myovant-sciences-ltd/defined-contribution-plan-cost-recognized https://stock.noler.com/us/stock/myovant-sciences-ltd/defined-contribution-plan-employer-matching-contribution-percent https://stock.noler.com/us/stock/myovant-sciences-ltd/defined-contribution-plan-employer-matching-contribution-percent-of-match https://stock.noler.com/us/stock/myovant-sciences-ltd/defined-contribution-plan-maximum-annual-contributions-per-employee-percent https://stock.noler.com/us/stock/myovant-sciences-ltd/depreciation https://stock.noler.com/us/stock/myovant-sciences-ltd/depreciation-and-amortization https://stock.noler.com/us/stock/myovant-sciences-ltd/derivative-liabilities https://stock.noler.com/us/stock/myovant-sciences-ltd/derivative-liabilities-noncurrent https://stock.noler.com/us/stock/myovant-sciences-ltd/diluted-shares https://stock.noler.com/us/stock/myovant-sciences-ltd/due-from-related-parties-current https://stock.noler.com/us/stock/myovant-sciences-ltd/due-to-related-parties-current https://stock.noler.com/us/stock/myovant-sciences-ltd/due-to-related-parties-noncurrent https://stock.noler.com/us/stock/myovant-sciences-ltd/earnings-per-share-basic-and-diluted https://stock.noler.com/us/stock/myovant-sciences-ltd/effective-tax-rate https://stock.noler.com/us/stock/myovant-sciences-ltd/employee-related-liabilities-current https://stock.noler.com/us/stock/myovant-sciences-ltd/eps https://stock.noler.com/us/stock/myovant-sciences-ltd/eps-basic https://stock.noler.com/us/stock/myovant-sciences-ltd/fair-value-adjustment-of-warrants https://stock.noler.com/us/stock/myovant-sciences-ltd/financing-cash-flow https://stock.noler.com/us/stock/myovant-sciences-ltd/foreign-currency-transaction-gain-before-tax https://stock.noler.com/us/stock/myovant-sciences-ltd/foreign-currency-transaction-gain-loss-before-tax https://stock.noler.com/us/stock/myovant-sciences-ltd/foreign-currency-transaction-gain-loss-unrealized https://stock.noler.com/us/stock/myovant-sciences-ltd/gains-losses-on-extinguishment-of-debt https://stock.noler.com/us/stock/myovant-sciences-ltd/general-and-administrative-expense https://stock.noler.com/us/stock/myovant-sciences-ltd/income-tax https://stock.noler.com/us/stock/myovant-sciences-ltd/income-tax-at-federal-statutory-rate https://stock.noler.com/us/stock/myovant-sciences-ltd/income-taxes-paid https://stock.noler.com/us/stock/myovant-sciences-ltd/income-taxes-receivable https://stock.noler.com/us/stock/myovant-sciences-ltd/increase-decrease-in-accounts-payable https://stock.noler.com/us/stock/myovant-sciences-ltd/increase-decrease-in-accounts-payable-and-accrued-liabilities https://stock.noler.com/us/stock/myovant-sciences-ltd/increase-decrease-in-accounts-payable-trade https://stock.noler.com/us/stock/myovant-sciences-ltd/increase-decrease-in-accounts-receivable https://stock.noler.com/us/stock/myovant-sciences-ltd/increase-decrease-in-accrued-income-taxes-payable https://stock.noler.com/us/stock/myovant-sciences-ltd/increase-decrease-in-accrued-liabilities https://stock.noler.com/us/stock/myovant-sciences-ltd/increase-decrease-in-accrued-liabilities-and-other-operating-liabilities https://stock.noler.com/us/stock/myovant-sciences-ltd/increase-decrease-in-contract-with-customer-liability https://stock.noler.com/us/stock/myovant-sciences-ltd/increase-decrease-in-deferred-income-taxes https://stock.noler.com/us/stock/myovant-sciences-ltd/increase-decrease-in-deferred-liabilities https://stock.noler.com/us/stock/myovant-sciences-ltd/increase-decrease-in-deferred-revenue https://stock.noler.com/us/stock/myovant-sciences-ltd/increase-decrease-in-due-from-related-parties-current https://stock.noler.com/us/stock/myovant-sciences-ltd/increase-decrease-in-due-to-related-parties-current https://stock.noler.com/us/stock/myovant-sciences-ltd/increase-decrease-in-income-taxes-payable-net-of-income-taxes-receivable https://stock.noler.com/us/stock/myovant-sciences-ltd/increase-decrease-in-income-taxes-receivable https://stock.noler.com/us/stock/myovant-sciences-ltd/increase-decrease-in-interest-payable-net https://stock.noler.com/us/stock/myovant-sciences-ltd/increase-decrease-in-inventories https://stock.noler.com/us/stock/myovant-sciences-ltd/increase-decrease-in-operating-lease-liability https://stock.noler.com/us/stock/myovant-sciences-ltd/increase-decrease-in-other-accounts-payable https://stock.noler.com/us/stock/myovant-sciences-ltd/increase-decrease-in-other-current-assets https://stock.noler.com/us/stock/myovant-sciences-ltd/increase-decrease-in-other-operating-assets https://stock.noler.com/us/stock/myovant-sciences-ltd/increase-decrease-in-other-operating-capital-net https://stock.noler.com/us/stock/myovant-sciences-ltd/increase-decrease-in-other-operating-liabilities https://stock.noler.com/us/stock/myovant-sciences-ltd/increase-decrease-in-prepaid-deferred-expense-and-other-assets https://stock.noler.com/us/stock/myovant-sciences-ltd/insider-transactions-stock-options https://stock.noler.com/us/stock/myovant-sciences-ltd/insider-transactions-stock-units https://stock.noler.com/us/stock/myovant-sciences-ltd/insider-transactions-warrants https://stock.noler.com/us/stock/myovant-sciences-ltd/interest-expense https://stock.noler.com/us/stock/myovant-sciences-ltd/interest-expense-other https://stock.noler.com/us/stock/myovant-sciences-ltd/interest-expense-related-party https://stock.noler.com/us/stock/myovant-sciences-ltd/interest-paid https://stock.noler.com/us/stock/myovant-sciences-ltd/interest-paid-net https://stock.noler.com/us/stock/myovant-sciences-ltd/interest-payable-current https://stock.noler.com/us/stock/myovant-sciences-ltd/interest-payable-current-and-noncurrent https://stock.noler.com/us/stock/myovant-sciences-ltd/inventory https://stock.noler.com/us/stock/myovant-sciences-ltd/inventory-finished-goods-net-of-reserves https://stock.noler.com/us/stock/myovant-sciences-ltd/inventory-raw-materials-net-of-reserves https://stock.noler.com/us/stock/myovant-sciences-ltd/inventory-work-in-process-net-of-reserves https://stock.noler.com/us/stock/myovant-sciences-ltd/investing-cash-flow https://stock.noler.com/us/stock/myovant-sciences-ltd/investment-income-interest https://stock.noler.com/us/stock/myovant-sciences-ltd/lease-cost https://stock.noler.com/us/stock/myovant-sciences-ltd/lessee-operating-lease-liability-payments-remainder-of-fiscal-year https://stock.noler.com/us/stock/myovant-sciences-ltd/lessee-operating-lease-liability-undiscounted-excess-amount https://stock.noler.com/us/stock/myovant-sciences-ltd/liabilities-fair-value-disclosure https://stock.noler.com/us/stock/myovant-sciences-ltd/long-term-debt https://stock.noler.com/us/stock/myovant-sciences-ltd/marketable-securities-current https://stock.noler.com/us/stock/myovant-sciences-ltd/marketable-securities-noncurrent https://stock.noler.com/us/stock/myovant-sciences-ltd/net-change-in-cash https://stock.noler.com/us/stock/myovant-sciences-ltd/net-income https://stock.noler.com/us/stock/myovant-sciences-ltd/noncash-or-part-noncash-acquisition-value-of-assets-acquired https://stock.noler.com/us/stock/myovant-sciences-ltd/number-of-operating-segments https://stock.noler.com/us/stock/myovant-sciences-ltd/number-of-reportable-segments https://stock.noler.com/us/stock/myovant-sciences-ltd/oci-foreign-currency-transaction-and-translation-adjustment-net-of-tax https://stock.noler.com/us/stock/myovant-sciences-ltd/oci-net-of-tax https://stock.noler.com/us/stock/myovant-sciences-ltd/oci-net-of-tax-2 https://stock.noler.com/us/stock/myovant-sciences-ltd/operating-cash-flow https://stock.noler.com/us/stock/myovant-sciences-ltd/operating-expenses https://stock.noler.com/us/stock/myovant-sciences-ltd/operating-income https://stock.noler.com/us/stock/myovant-sciences-ltd/operating-lease-assets https://stock.noler.com/us/stock/myovant-sciences-ltd/operating-lease-cost https://stock.noler.com/us/stock/myovant-sciences-ltd/operating-lease-liability https://stock.noler.com/us/stock/myovant-sciences-ltd/operating-lease-liability-current https://stock.noler.com/us/stock/myovant-sciences-ltd/operating-lease-liability-noncurrent https://stock.noler.com/us/stock/myovant-sciences-ltd/operating-lease-payments https://stock.noler.com/us/stock/myovant-sciences-ltd/operating-lease-payments-due https://stock.noler.com/us/stock/myovant-sciences-ltd/operating-lease-payments-due-2 https://stock.noler.com/us/stock/myovant-sciences-ltd/operating-lease-payments-due-after-year-five https://stock.noler.com/us/stock/myovant-sciences-ltd/operating-lease-payments-due-current https://stock.noler.com/us/stock/myovant-sciences-ltd/operating-lease-payments-due-in-five-years https://stock.noler.com/us/stock/myovant-sciences-ltd/operating-lease-payments-due-in-four-years https://stock.noler.com/us/stock/myovant-sciences-ltd/operating-lease-payments-due-in-three-years https://stock.noler.com/us/stock/myovant-sciences-ltd/operating-lease-payments-due-in-two-years https://stock.noler.com/us/stock/myovant-sciences-ltd/operating-lease-payments-due-next-twelve-months https://stock.noler.com/us/stock/myovant-sciences-ltd/operating-lease-payments-due-thereafter https://stock.noler.com/us/stock/myovant-sciences-ltd/operating-lease-payments-due-year-five https://stock.noler.com/us/stock/myovant-sciences-ltd/operating-lease-payments-due-year-four https://stock.noler.com/us/stock/myovant-sciences-ltd/operating-lease-payments-due-year-three https://stock.noler.com/us/stock/myovant-sciences-ltd/operating-lease-payments-due-year-two https://stock.noler.com/us/stock/myovant-sciences-ltd/operating-lease-right-of-use-asset-amortization-expense https://stock.noler.com/us/stock/myovant-sciences-ltd/operating-lease-weighted-average-discount-rate-percent https://stock.noler.com/us/stock/myovant-sciences-ltd/operating-leases-rent-expense-net https://stock.noler.com/us/stock/myovant-sciences-ltd/other-accrued-liabilities-current https://stock.noler.com/us/stock/myovant-sciences-ltd/other-noncash-income-expense https://stock.noler.com/us/stock/myovant-sciences-ltd/other-noncurrent-assets https://stock.noler.com/us/stock/myovant-sciences-ltd/other-noncurrent-liabilities https://stock.noler.com/us/stock/myovant-sciences-ltd/other-nonoperating-expense https://stock.noler.com/us/stock/myovant-sciences-ltd/other-nonoperating-income-expense https://stock.noler.com/us/stock/myovant-sciences-ltd/other-operating-activities-cash-flow-statement https://stock.noler.com/us/stock/myovant-sciences-ltd/paid-in-capital-shares-issued-issuance-costs https://stock.noler.com/us/stock/myovant-sciences-ltd/paid-in-capital-stock-compensation https://stock.noler.com/us/stock/myovant-sciences-ltd/paid-in-capital-warrant-issued https://stock.noler.com/us/stock/myovant-sciences-ltd/payments-of-stock-issuance-costs https://stock.noler.com/us/stock/myovant-sciences-ltd/payments-to-acquire-marketable-securities https://stock.noler.com/us/stock/myovant-sciences-ltd/prepaid-expense-and-other-assets-current https://stock.noler.com/us/stock/myovant-sciences-ltd/pretax-income https://stock.noler.com/us/stock/myovant-sciences-ltd/pretax-income-domestic https://stock.noler.com/us/stock/myovant-sciences-ltd/proceeds-from-collaborators https://stock.noler.com/us/stock/myovant-sciences-ltd/proceeds-from-contributions-from-parent https://stock.noler.com/us/stock/myovant-sciences-ltd/proceeds-from-debt-net-of-issuance-costs https://stock.noler.com/us/stock/myovant-sciences-ltd/proceeds-from-issuance-initial-public-offering https://stock.noler.com/us/stock/myovant-sciences-ltd/proceeds-from-issuance-of-other-long-term-debt https://stock.noler.com/us/stock/myovant-sciences-ltd/proceeds-from-related-party-debt https://stock.noler.com/us/stock/myovant-sciences-ltd/proceeds-from-sale-and-maturity-of-marketable-securities https://stock.noler.com/us/stock/myovant-sciences-ltd/proceeds-from-stock-issued https://stock.noler.com/us/stock/myovant-sciences-ltd/proceeds-from-stock-options-exercised https://stock.noler.com/us/stock/myovant-sciences-ltd/property-plant-equipment https://stock.noler.com/us/stock/myovant-sciences-ltd/public-float https://stock.noler.com/us/stock/myovant-sciences-ltd/related-party-transaction-selling-general-and-administrative-expenses-from-transactions-with-related-party https://stock.noler.com/us/stock/myovant-sciences-ltd/repayments-of-other-long-term-debt https://stock.noler.com/us/stock/myovant-sciences-ltd/research-and-development https://stock.noler.com/us/stock/myovant-sciences-ltd/research-and-development-asset-acquired-other-than-through-acquisition-written-off https://stock.noler.com/us/stock/myovant-sciences-ltd/restricted-cash https://stock.noler.com/us/stock/myovant-sciences-ltd/restricted-cash-current https://stock.noler.com/us/stock/myovant-sciences-ltd/restricted-cash-noncurrent https://stock.noler.com/us/stock/myovant-sciences-ltd/retained-earnings https://stock.noler.com/us/stock/myovant-sciences-ltd/revenue https://stock.noler.com/us/stock/myovant-sciences-ltd/revenue-from-collaborative-arrangement-excluding-revenue-from-contract-with-customer https://stock.noler.com/us/stock/myovant-sciences-ltd/revenue-from-contract-with-customer-excluding-assessed-tax https://stock.noler.com/us/stock/myovant-sciences-ltd/revenue-remaining-performance-obligation https://stock.noler.com/us/stock/myovant-sciences-ltd/right-of-use-asset-obtained-in-exchange-for-operating-lease-liability https://stock.noler.com/us/stock/myovant-sciences-ltd/sga-expense https://stock.noler.com/us/stock/myovant-sciences-ltd/share-price https://stock.noler.com/us/stock/myovant-sciences-ltd/shareholders-equity https://stock.noler.com/us/stock/myovant-sciences-ltd/shares-authorized https://stock.noler.com/us/stock/myovant-sciences-ltd/shares-issued https://stock.noler.com/us/stock/myovant-sciences-ltd/shares-issued-price-per-share https://stock.noler.com/us/stock/myovant-sciences-ltd/shares-issued-shares-purchase-of-assets https://stock.noler.com/us/stock/myovant-sciences-ltd/short-term-lease-cost https://stock.noler.com/us/stock/myovant-sciences-ltd/significant-change-in-utb-is-reasonably-possible-amount-of-unrecorded-benefit https://stock.noler.com/us/stock/myovant-sciences-ltd/stock-award-accelerated-compensation-cost https://stock.noler.com/us/stock/myovant-sciences-ltd/stock-award-fair-value-assumptions-expected-dividend-rate https://stock.noler.com/us/stock/myovant-sciences-ltd/stock-award-fair-value-assumptions-expected-volatility-rate https://stock.noler.com/us/stock/myovant-sciences-ltd/stock-award-fair-value-assumptions-risk-free-interest-rate https://stock.noler.com/us/stock/myovant-sciences-ltd/stock-award-options-exercises-in-period-average-exercise-price https://stock.noler.com/us/stock/myovant-sciences-ltd/stock-award-options-forfeitures-in-period-average-exercise-price https://stock.noler.com/us/stock/myovant-sciences-ltd/stock-award-options-grants-in-period-average-exercise-price https://stock.noler.com/us/stock/myovant-sciences-ltd/stock-award-rsu-aggregate-intrinsic-value-outstanding https://stock.noler.com/us/stock/myovant-sciences-ltd/stock-based-compensation https://stock.noler.com/us/stock/myovant-sciences-ltd/stock-compensation-allocation-of-recognized-period-costs-capitalized-amount https://stock.noler.com/us/stock/myovant-sciences-ltd/stock-compensation-unrecognized-cost https://stock.noler.com/us/stock/myovant-sciences-ltd/stock-issued-new-shares-sold https://stock.noler.com/us/stock/myovant-sciences-ltd/stock-issued-shares-issued-for-options-exercised https://stock.noler.com/us/stock/myovant-sciences-ltd/stock-issued-shares-issued-value-purchase-of-assets https://stock.noler.com/us/stock/myovant-sciences-ltd/stock-issued-shares-issued-value-stock-options-exercised https://stock.noler.com/us/stock/myovant-sciences-ltd/stock-issued-value-of-shares-issued-for-stock-awards https://stock.noler.com/us/stock/myovant-sciences-ltd/stock-options-exercisable-average-exercise-price https://stock.noler.com/us/stock/myovant-sciences-ltd/stock-options-exercisable-intrinsic-value https://stock.noler.com/us/stock/myovant-sciences-ltd/stock-options-exercisable-number https://stock.noler.com/us/stock/myovant-sciences-ltd/stock-options-exercises-in-period-total-intrinsic-value https://stock.noler.com/us/stock/myovant-sciences-ltd/stock-options-forfeitures-in-period https://stock.noler.com/us/stock/myovant-sciences-ltd/stock-options-grants-in-period-grant-date-fair-value https://stock.noler.com/us/stock/myovant-sciences-ltd/stock-options-grants-in-period-gross https://stock.noler.com/us/stock/myovant-sciences-ltd/stock-options-nonvested-grant-date-fair-value https://stock.noler.com/us/stock/myovant-sciences-ltd/stock-options-outstanding-average-exercise-price https://stock.noler.com/us/stock/myovant-sciences-ltd/stock-options-outstanding-intrinsic-value https://stock.noler.com/us/stock/myovant-sciences-ltd/stock-options-outstanding-number https://stock.noler.com/us/stock/myovant-sciences-ltd/stock-options-vested-and-expected-to-vest-outstanding-aggregate-intrinsic-value https://stock.noler.com/us/stock/myovant-sciences-ltd/stock-options-vested-and-expected-to-vest-outstanding-average-exercise-price https://stock.noler.com/us/stock/myovant-sciences-ltd/stock-options-vested-and-expected-to-vest-outstanding-number https://stock.noler.com/us/stock/myovant-sciences-ltd/stock-options-vested-in-period-fair-value https://stock.noler.com/us/stock/myovant-sciences-ltd/stock-options-vested-number-of-shares https://stock.noler.com/us/stock/myovant-sciences-ltd/stock-split-ratio https://stock.noler.com/us/stock/myovant-sciences-ltd/tax-rate-reconciliation-at-federal-statutory-income-tax-rate https://stock.noler.com/us/stock/myovant-sciences-ltd/tax-rate-reconciliation-change-in-deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/myovant-sciences-ltd/tax-rate-reconciliation-change-in-enacted-tax-rate https://stock.noler.com/us/stock/myovant-sciences-ltd/tax-rate-reconciliation-foreign-income-tax-rate-differential https://stock.noler.com/us/stock/myovant-sciences-ltd/tax-rate-reconciliation-nondeductible-expense-share-based-compensation-cost https://stock.noler.com/us/stock/myovant-sciences-ltd/tax-rate-reconciliation-other-adjustments https://stock.noler.com/us/stock/myovant-sciences-ltd/tax-rate-reconciliation-tax-contingencies https://stock.noler.com/us/stock/myovant-sciences-ltd/tax-rate-reconciliation-tax-credits-research https://stock.noler.com/us/stock/myovant-sciences-ltd/tax-reconciliation-change-in-deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/myovant-sciences-ltd/tax-reconciliation-change-in-enacted-tax-rate https://stock.noler.com/us/stock/myovant-sciences-ltd/tax-reconciliation-foreign-income-tax-rate-differential https://stock.noler.com/us/stock/myovant-sciences-ltd/tax-reconciliation-nondeductible-expense-share-based-compensation-cost https://stock.noler.com/us/stock/myovant-sciences-ltd/tax-reconciliation-other-adjustments https://stock.noler.com/us/stock/myovant-sciences-ltd/tax-reconciliation-tax-contingencies https://stock.noler.com/us/stock/myovant-sciences-ltd/tax-reconciliation-tax-credits-research https://stock.noler.com/us/stock/myovant-sciences-ltd/tax-withholding-on-stock-awards https://stock.noler.com/us/stock/myovant-sciences-ltd/total-assets https://stock.noler.com/us/stock/myovant-sciences-ltd/total-contract-liability https://stock.noler.com/us/stock/myovant-sciences-ltd/total-liabilities https://stock.noler.com/us/stock/myovant-sciences-ltd/total-liabilities-and-equity https://stock.noler.com/us/stock/myovant-sciences-ltd/total-long-term-debt https://stock.noler.com/us/stock/myovant-sciences-ltd/unrecognized-tax-benefits https://stock.noler.com/us/stock/myovant-sciences-ltd/utb-change https://stock.noler.com/us/stock/myovant-sciences-ltd/utb-decrease-from-prior-year-positions https://stock.noler.com/us/stock/myovant-sciences-ltd/utb-income-tax-penalties-and-interest-accrued https://stock.noler.com/us/stock/myovant-sciences-ltd/utb-income-tax-penalties-and-interest-expense https://stock.noler.com/us/stock/myovant-sciences-ltd/utb-increase-from-current-year-positions https://stock.noler.com/us/stock/myovant-sciences-ltd/utb-increase-from-prior-year-positions https://stock.noler.com/us/stock/myovant-sciences-ltd/valuation-allowance-deferred-tax-asset-change-in-amount https://stock.noler.com/us/stock/myovant-sciences-ltd/valuation-allowances-and-reserves-balance https://stock.noler.com/us/stock/myovant-sciences-ltd/variable-lease-cost https://stock.noler.com/us/stock/myovant-sciences-ltd/weighted-average-number-of-share-outstanding-basic-and-diluted